Citation Impact
Citing Papers
Vaginal microbiome of reproductive-age women
2010 Standout
Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial
2012 Standout
Transient Ablation of Regulatory T cells Improves Antitumor Immunity in Colitis-Associated Colon Cancer
2014 StandoutNobel
Mucosal healing in inflammatory bowel diseases: a systematic review
2012 Standout
Development and validation of the Nancy histological index for UC
2015 Standout
Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment
2012 Standout
Environmentally-acquired bacteria influence microbial diversity and natural innate immune responses at gut surfaces
2009
DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants
2016 Standout
Atopic Dermatitis
2008 Standout
Systemic and topical steroids in inflammatory bowel disease
2004
European evidence based consensus on the diagnosis and management of Crohn’s disease: current management
2006
Symptomatic overlap between irritable bowel syndrome and microscopic colitis
2006
NF-κB signaling in inflammation
2017 Standout
Postinfectious Irritable Bowel Syndrome
2009
Bowel Disorders
2016 Standout
The role of bacteria and pattern-recognition receptors in Crohn's disease
2011
Ulcerative Colitis
2011 Standout
Functional polymorphisms in LPS receptors CD14 and TLR4 are not associated with disease susceptibility or Campylobacter jejuni infection in Guillain–Barré patients
2004
Unravelling the pathogenesis of inflammatory bowel disease
2007 StandoutNature
Genetic Analysis of Innate Immunity
2006 StandoutNobel
Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease
2011 Standout
Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease
2003 Standout
A cytokine-mediated link between innate immunity, inflammation, and cancer
2007 Standout
Physiology and immunology of the cholinergic antiinflammatory pathway
2007 Standout
Recognition of microorganisms and activation of the immune response
2007 StandoutNature
Inflammatory bowel disease: clinical aspects and established and evolving therapies
2007 Standout
Crohn's disease
2012 Standout
Dichotomic Nature of Atopic Dermatitis Reflected by Combined Analysis of Monocyte Immunophenotyping and Single Nucleotide Polymorphisms of the Interleukin-4/Interleukin-13 Receptor Gene: The Dichotomy of Extrinsic and Intrinsic Atopic Dermatitis
2002
The Oslo definitions for coeliac disease and related terms
2012 Standout
Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study Of Liver Diseases and the European Association for the Study of the Liver
2014 Standout
Pattern Recognition Receptors and Inflammation
2010 Standout
Single nucleotide polymorphisms in TNFSF15 confer susceptibility to Crohn's disease
2005
ATP-sensitive potassium channels mediate survival during infection in mammals and insects
2007 StandoutNobel
Inflammatory bowel disease: cause and immunobiology
2007 Standout
A Randomized, Placebo-Controlled Trial of Certolizumab Pegol (CDP870) for Treatment of Crohn’s Disease
2005
Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline
2016 Standout
Inflammatory Bowel Disease
2009 Standout
dbAARD & AGP: A computational pipeline for the prediction of genes associated with age related disorders
2016
IL-6 in autoimmune disease and chronic inflammatory proliferative disease
2002
The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota
2002 Standout
Role of the Microbiota in Immunity and Inflammation
2014 Standout
Pharmacokinetics and Pharmacodynamics of Systemically Administered Glucocorticoids
2005
A Simple Classification of Crohnʼs Disease: Report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998
2000 Standout
The Functional Gastrointestinal Disorders and the Rome III Process
2006 Standout
Crohn's disease
2016 Standout
Role of the NFKB1 −94ins/delATTG promoter polymorphism in IBD and potential interactions with polymorphisms in the CARD15/NOD2, IKBL, and IL-1RN genes
2006
Modulation of the innate immune response within the periodontium
2004
Differential Effects of NOD2 Variants on Crohn's Disease Risk and Phenotype in Diverse Populations: A Metaanalysis
2004
New pathophysiological insights and modern treatment of IBD
2010
Periodontitis: from microbial immune subversion to systemic inflammation
2014 Standout
Deficient host-bacteria interactions in inflammatory bowel disease? The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn’s disease and ulcerative colitis
2004
Prophylaxis of hepatic encephalopathy in acute variceal bleed: A randomized controlled trial of lactulose versus no lactulose
2010
Ulcerative colitis
2016 Standout
Pharmacokinetic Considerations in the Treatment of Inflammatory Bowel Disease
2001
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management
2010
Evolving knowledge and therapy of inflammatory bowel disease
2006
NOD2/CARD15, TLR4 and CD14 mutations in Scottish and Irish Crohn's disease patients: evidence for genetic heterogeneity within Europe?
2004
Periodontitis: a polymicrobial disruption of host homeostasis
2010 Standout
The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications
2006 Standout
Postinfectious irritable bowel syndrome1 1Abbreviations used in this paper: EC,_; IBS, irritable bowel syndrome; PI, postinfective.
2003
Molecular pathogenesis of inflammatory bowel disease: Genotypes, phenotypes and personalized medicine
2007
Epidemiology and Natural History of Inflammatory Bowel Diseases
2011 Standout
Systematic review: the effectiveness of budesonide therapy for Crohn's disease
2002
Reduced diversity of faecal microbiota in Crohn’s disease revealed by a metagenomic approach
2005 Standout
Cytokine storm in acute pancreatitis.
2002
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
2010 Standout
Interleukin-10-based therapy for inflammatory bowel disease
2003
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
2013 Standout
Glucocorticosteroid Therapy in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis
2011
Antagonistic activity against pathogenic bacteria by human vaginal lactobacilli
2006
Interplay of commensal and pathogenic bacteria, genetic mutations, and immunoregulatory defects in the pathogenesis of inflammatory bowel diseases
2008
A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease
2002
Pathogen Recognition and Innate Immunity
2006 Standout
Guillain-Barré syndrome
2005 Standout
The limitations of corticosteroid therapy in Crohn’s disease
2001
Impacts of biodiversity on the emergence and transmission of infectious diseases
2010 StandoutNature
The human microbiome: at the interface of health and disease
2012 Standout
An Evidence-Based Systematic Review on Medical Therapies for Inflammatory Bowel Disease
2011
A simple classification of Crohn's disease: Report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998
2007
Role of cytokines in inflammatory bowel disease
2008
Gut Microbiota in Health and Disease
2010 Standout
Toward a live microbial microbicide for HIV: Commensal bacteria secreting an HIV fusion inhibitor peptide
2005
Engineering microbial consortia: a new frontier in synthetic biology
2008 StandoutNobel
Pathogenesis ofHelicobacter pyloriInfection
2006 Standout
Inflammatory Bowel Disease
2010 Standout
Global Epidemiology of Campylobacter Infection
2015 Standout
Frequencies of Genetic Polymorphisms of TLR4 and CD14 and of HLA‐DQ Genotypes in Children With Celiac Disease, Type 1 Diabetes Mellitus, or Both
2008
Genetic polymorphism of interleukin-8 (IL-8) is associated with Helicobacter pylori-induced duodenal ulcer.
2005
Genetic susceptibility to periodontitis
2011
Budesonide for induction of remission in Crohn's disease
2015
NOD-LRR PROTEINS: Role in Host-Microbial Interactions and Inflammatory Disease
2005
Clinical Implications of Inflammatory Bowel Disease Genetics on Phenotype
2005
Regulation and Functions of the IL-10 Family of Cytokines in Inflammation and Disease
2011 Standout
Targeting enteric bacteria in treatment of inflammatory bowel diseases
2003
Works of A Tromm being referenced
Oral pH-modified release budesonide versus 6-methylprednisolone in active Crohn's disease. German/Austrian Budesonide Study Group.
1996
Budesonide treatment for collagenous colitis: A randomized, double-blind, placebo-controlled, multicenter trial
2002
Evaluation of Different Laboratory Tests and Activity Indices Reflecting the Inflammatory Activity of Crohn's Disease
1992
A polymorphism of the NFKBIA gene is associated with Crohn's disease patients lacking a predisposing allele of the CARD15 gene
2004
The ProbioticE. coliStrain Nissle 1917 for the Treatment of Collagenous Colitis: First Results of an Open-Label Trial
2004
The polymorphism at position –174 of the IL-6 gene is not associated with inflammatory bowel disease
2001
Interleukin-4 and interleukin-4 receptor gene polymorphisms in inflammatory bowel diseases
2001
A Polymorphism in the CD14 Gene is Associated with Crohn Disease
2002
TheIL-10 gene is not involved in the predisposition to inflammatory bowel disease
2000
A Polymorphism of the Bactericidal/Permeability Increasing Protein (BPI) Gene Is Associated With Crohn's Disease
2005
Interleukin-4 inhibits the increased production of vascular endothelial growth factor by peripheral blood mononuclear cells in patients with inflammatory bowel disease.
2001
Orthograde whole gut irrigation with mannite versus paromomycine + lactulose as prophylaxis of hepatic encephalopathy in patients with cirrhosis and upper gastrointestinal bleeding: results of a controlled randomized trial.
2000
Oral mesalazine for the treatment of Crohn's disease: clinical efficacy with respect to pharmacokinetic properties.
2000
Mechanism-based PK/PD model for the lymphocytopenia induced by endogenous and exogenous corticosteroids.
1999
Interaction of Polymorphisms in the CARD15 and CD14 Genes in Patients with Crohn Disease
2003